[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341992-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341992-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-microbial-composition-of-pancreatic-ductal-adenocarcinoma-a-systematic-review-of-16s-rrna-gene-sequencing","The microbial composition of pancreatic ductal adenocarcinoma - A systematic review of 16S rRNA gene sequencing","","Pancreatic ductal adenocarcinoma (PDAC) remains a major clinical and scientific challenge, and recent evidence suggests PDAC tumors contain a characteristic microbiome distinct from healthy tissue. This systematic review evaluates and summarizes PDAC studies using 16S rRNA gene amplicon sequencing across bodily compartments, following PRISMA guidelines. From 1,727 screened studies, 38 were included for qualitative analysis, identifying multiple bacterial signatures. No universal 16S rRNA signature can be recommended for PDAC screening due to result heterogeneity, limited datasets, and selection bias. The review highlights emerging work on causal links and emphasizes the need for standardized data and consensus guidelines to enable targetable microbial signatures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-microbial-composition-of-pancreatic-ductal-adenocarcinoma-a-systematic-review-of-16s-rrna-gene-sequencing/341992/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-microbial-composition-of-pancreatic-ductal-adenocarcinoma-a-systematic-review-of-16s-rrna-gene-sequencing/341992.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this systematic review?","Question",{"text":63,"@type":64},"To evaluate and summarize all PDAC studies that used 16S rRNA gene amplicon sequencing within each bodily compartment, and to consider links between PDAC and the microbiome.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the studies selected and analyzed?",{"text":68,"@type":64},"The review followed PRISMA guidelines, using a comprehensive search strategy. From 1,727 studies analyzed, 38 were selected for qualitative analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is there no universal 16S rRNA gene microbial signature for PDAC screening?",{"text":72,"@type":64},"Because of heterogeneity in reported results, lack of available datasets, and intrinsic selection bias between studies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341992,1790641797,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Systematic Review and/or Meta-analysis   \n’   \nThe microbial composition of pancreatic ductaladenocarcinoma: a systematic review of 16S rRNA gene sequencing  \nNabeel Merali, MBBS, MSc, MRCS (Eng)a,b,c , Tarak Chouari, BSc, MBChB, MRCS (Eng)a,c ,  \nCasie Sweeney, LtCol (USMCR), BA, BSc, MBChB, MSca , James Halle-Smith, BMedSc, MBChB, MRCS (Eng)j , Maria-Danae Jessel, BScc , Bing Wang, PhDk , James O’ Brien, MBBS, BSc, MRCS (Eng)a , Satoshi Suyama, PhDf, José I. Jiménez, PhDg , Keith J. Roberts, PhD, FRCS (Gen Surg)j , Eirini Velliou, MEng, PhDh , Shivan Sivakumar, PhDi , Timothy A. Rockall, MD, FRCS (Gen Surg)a , Ayse Demirkan, PhDd,e , Virginia Pedicord, PhDf, Dongmei Deng, PhDl , Elisa Giovannetti, MD, PhDk,m , Nicola E. Annels, PhDc ,  \nAdam E. Frampton, BSc, MSc, PhD, FRCS (Gen Surg), FRSBa,b,c,*  \nBackground: Pancreatic cancer, speciﬁcally pancreatic ductal adenocarcinoma (PDAC), continues to pose a signiﬁcant clinical and scientiﬁc challenge. The most signiﬁcant ﬁnding of recent years is that PDAC tumours harbour their speciﬁc microbiome, which differs amongst tumour entities and is distinct from healthy tissue. This review aims to evaluate and summarise all PDAC studies that have used the next-generation technique, 16S rRNA gene amplicon sequencing within each bodily compartment. As well as establishing a causal relationship between PDAC and the microbiome.  \nMaterials and methods: This systematic review was carried out according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A comprehensive search strategy was designed, and 1727 studies were analysed. Results: In total, 38 studies were selected for qualitative analysis and summarised signiﬁcant PDAC bacterial signatures. Despite the growing amount of data provided, we are not able to state a universal 16S rRNA gene microbial signature that can be used for PDAC screening. This is most certainly due to the heterogeneity of the presentation of results, lack of available datasets, and the intrinsic selection bias between studies.  \nConclusion: Several key studies have begun to shed light on causality and the inﬂuence the microbiome constituentsand their produced metabolites could play in tumorigenesis and inﬂuencing outcomes . The challenge in this ﬁeld is to shape the available microbial data into targetable signatures . Making sequenced data readily available is critical, coupled with the coordinated standardisation of data and the need for consensus guidelines in studies investigating the microbiome in PDAC.  \nKeywords: 16sRNA gene, biomarker, cancer therapy, microbiome, pancreatic cancer, pancreatic ductal adenocarcinoma, signature  \naMinimal Access Therapy Training Unit (MATTU), Royal Surrey Hospital NHS Foundation Trust, bDepartment of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital NHS Foundation Trust, cSection of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, dSection of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, eSurrey Institute for People-Centred AI, University of Surrey, Guildford, Surrey, fCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, gDepartment of Life Sciences, Imperial College London, hCentre for 3D Models of Health and Disease, Division of Surgery and Interventional Science, University College London (UCL), London, iOncology Department and Institute of Immunology and Immunotherapy, Birmingham Medical School, University of Birmingham, jHepatobiliary and Pancreatic Surgery Unit, Queen Elizabeth Hospital Birmingham, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK, kDepartment of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, lDepartment of Preventive Dentistry, Academic Center for Dentistry Amsterdam (ACTA), U","cbCaiiALYmmlhziJ","https://ap.wps.com/l/cbCaiiALYmmlhziJ","pdf",891991,29,"English","# Background\n# Materials and methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the purpose of this systematic review?\",\"answer\":\"To evaluate and summarize all PDAC studies that used 16S rRNA gene amplicon sequencing within each bodily compartment, and to consider links between PDAC and the microbiome.\"},{\"question\":\"How were the studies selected and analyzed?\",\"answer\":\"The review followed PRISMA guidelines, using a comprehensive search strategy. From 1,727 studies analyzed, 38 were selected for qualitative analysis.\"},{\"question\":\"Why is there no universal 16S rRNA gene microbial signature for PDAC screening?\",\"answer\":\"Because of heterogeneity in reported results, lack of available datasets, and intrinsic selection bias between studies.\"}]","The microbial composition of pancreatic ductal adenocarcinoma - A systematic review of 16S rRNA gene sequencing | PDF",1790044666,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84089d1289e8989aa09df6bcac6ad3c5.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/616ab5d3789cf2ff1760fc4a744371d9.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ecd9b159d150a88ee1e241c180b8cac.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/091311e02665055c64669ab47c0df93a.webp",980,1306]